Sotalol Hydrochloride Tablet
Product Images NDC 72789-137

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 72789-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789135 Label (72789135)

Label for Sotalol Hydrochloride Tablets, USP 160 mg in a bottle of 100 tablets. The label includes storage instructions, dosage information, and manufacturer details, showing PD-Rx Pharmaceuticals, Inc. as the marketer and Oxford Pharmaceuticals, LLC as the manufacturer. It is marked Rx Only with NDC 72789-135-01.*

FDA Label Image

72789136 Label (72789136)

Packaging label for Sotalol Hydrochloride Tablets USP, 240 mg strength, containing 100 tablets. The label shows the NDC 72789-136-01 and indicates the product is for prescription use only (Rx Only). It is marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

72789137 Label (72789137)

Label for Sotalol Hydrochloride Tablets USP 80 mg, oral tablet form, with a quantity of 100 tablets. The label includes storage instructions, dispensing guidance, and contact information for PD-Rx Pharmaceuticals, Inc., the marketer and packager, as well as Oxford Pharmaceuticals, LLC, the manufacturer. The label features the NDC 72789-137-01 and indicates prescription-only use.*

FDA Label Image

72789138 Label (72789138)

Label for Sotalol Hydrochloride Tablets USP 120 mg, oral tablets, packaged in a 100-tablet container. The label includes storage instructions, a barcode, and states the product is Rx Only. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, LLC, Birmingham, Alabama.*

FDA Label Image

Age About 2 Years Or Younger (Age Factor)

A line graph depicting the relationship between Age Factor and Age in months. The Age Factor increases steadily from about 0.2 at 0.1 months to 1.0 at over 24 months, showing a gradual rise as age increases. Axes are labeled with Age Factor on the vertical axis and Age, months on the horizontal axis.*

FDA Label Image

Figure 2 (Figure2)

A Kaplan-Meier curve graph showing recurrence-free survival over time (days) comparing oral Sotalol Hydrochloride at doses of 80 mg, 120 mg, and 160 mg against placebo. The vertical axis represents recurrence-free survival proportion, and the horizontal axis represents time in days up to 360. P-values from log-rank tests for each dose versus placebo are displayed.*

FDA Label Image

Figure 3 (Figure3)

A Kaplan-Meier survival curve graph showing recurrence-free survival over time in days. It compares oral Sotalol Hydrochloride (AF) to placebo, with Sotalol showing higher survival rates. The chart includes a p-value (0.002) indicating statistical significance using the Log-Rank test.*

FDA Label Image

Molecular Structure (Molecularstructure)

Chemical structure of Sotalol Hydrochloride, showing its molecular composition and arrangement with key functional groups and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.